Remove Hospitals Remove Medication Labelling Remove Webinar
article thumbnail

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

These changes allow pharmacists to effectively support safer pain management through communication, medication review, and interdisciplinary collaboration, with the final result being better outcomes and reduced opioid-related harm. FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks. REFERENCES 1.

article thumbnail

Five for Friday February 24: Celebrating Success in Advancing Medication Use Quality

PQA

-- Richard Schmitz, PQA Chief Engagement Officer Investigating Impact of Discontinuation Rates for Oral Oncolytics Results from a Walgreens study show that increased medication adherence on cycled oral antineoplastics can lead to lower medical costs and fewer hospitalization events compared with lower adherence levels.